Clovis Oncology CLVS announced Tuesday the pricing of an
underwritten public offering of 3,333,334 shares of its common stock at
$72.00 per share, before underwriting discounts and commissions. The
size of the offering was upsized from $170 million to $240 million. In
addition, the underwriters have a 30-day option to purchase up to an
additional 486,110 shares of common stock from Clovis Oncology to cover
over-allotments, if any.
The offering is expected to close on June 17, 2013, subject to customary
closing conditions.
Clovis Oncology intends to use the net proceeds of the offering for
general corporate purposes, including funding of its development
programs, general and administrative
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in